Cargando…

Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution

Pediatric myelodysplastic syndrome (MDS) is an uncommon disease and little is known about the molecular alterations of its development and evolution to acute myeloid leukemia (AML). The Enhancer of Zeste Homolog 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2 (PCR2). It is a histo...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza Fernandez, Teresa, Fonseca Alvarenga, Tatiana, Almeida Antônio de Kós, Elaiza, Lamim Lovatel, Viviane, Tavares, Rita de Cássia, da Costa, Elaine Sobral, de Souza Fernandez, Cecília, Abdelhay, Eliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925750/ https://www.ncbi.nlm.nih.gov/pubmed/31886200 http://dx.doi.org/10.1155/2019/3176565

Ejemplares similares

Expression Profiles of DNA Methylation and Demethylation Machinery Components in Pediatric Myelodysplastic Syndrome: Clinical Implications
por: Lamim Lovatel, Viviane, et al.
Publicado: (2020)

A Novel Constitutional t(3;8)(p26;q21) and ANKRD26 and SRP72 Variants in a Child with Myelodysplastic Neoplasm: Clinical Implications
por: Lovatel, Viviane Lamim, et al.
Publicado: (2023)

An uncommon t(9;11)(p24;q22) with monoallelic loss of ATM and KMT2A genes in a child with myelodysplastic syndrome/acute myeloid leukemia who evolved from Fanconi anemia
por: Lovatel, Viviane Lamim, et al.
Publicado: (2018)

Myelodysplastic syndrome with clonal karyotype evolution associated with trisomy 8 and ASXL1 mutation in well‐controlled HIV patient: Case report and literature review
por: Mendes‐de‐Almeida, Daniela Palheiro, et al.
Publicado: (2020)

Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome Presenting t(11;16)(q23;q24)
por: Lamim Lovatel, Viviane, et al.
Publicado: (2022)

Cytogenetic as an Important Tool for Diagnosis and Prognosis for Patients with Hypocellular Primary Myelodysplastic Syndrome
por: Corrêa de Souza, Daiane, et al.
Publicado: (2014)

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
por: van Spronsen, Margot F., et al.
Publicado: (2023)

Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: Report of a new case and review of the literature
por: Otero, Luize, et al.
Publicado: (2012)

PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features
por: Teye, Emmanuel K., et al.
Publicado: (2017)

A unique set of complex chromosomal abnormalities in an infant with myeloid leukemia associated with Down syndrome
por: de Souza, Daiane Correa, et al.
Publicado: (2017)

Predicting leukemic transformation in myelodysplastic syndrome using a transcriptomic signature
por: Guo, Chao, et al.
Publicado: (2023)

Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome
por: Aoyama, Kazumasa, et al.
Publicado: (2018)

FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
por: Schieber, Michael, et al.
Publicado: (2020)

Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
por: Muto, Tomoya, et al.
Publicado: (2013)

Techniques for detecting chromosomal aberrations in myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

Acute promyelocytic leukemia in a long-standing HIV-positive patient: Case report and literature review
por: Mendes-de-Almeida, Daniela P., et al.
Publicado: (2022)

Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells
por: da Rocha, M M, et al.
Publicado: (2011)

Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
por: Veija, Tuukka, et al.
Publicado: (2017)

miRNome Profiling Reveals Shared Features in Breast Cancer Subtypes and Highlights miRNAs That Potentially Regulate MYB and EZH2 Expression
por: Corrêa, Stephany, et al.
Publicado: (2021)

Identify latent chromosomal aberrations relevant to myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

Aberrant Methylation-Mediated Suppression of APAF1 in Myelodysplastic Syndrome
por: Zaker, Farhad, et al.
Publicado: (2017)

SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome
por: Ma, Yan, et al.
Publicado: (2015)

Fatal right‐sided heart failure due to leukostasis in a patient with leukemic transformation of myelodysplastic syndrome
por: Pryds, Kasper, et al.
Publicado: (2018)

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome
por: Xu, Feng, et al.
Publicado: (2016)

U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes
por: Komrokji, Rami, et al.
Publicado: (2022)

Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosis
por: Hong, Minghua, et al.
Publicado: (2021)

Renal Leukemic Infiltration Overlapping Acute Focal Bacterial Nephritis during Myelodysplastic Syndrome: An Autopsy Case Report
por: Murakami, Keishu, et al.
Publicado: (2022)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes
por: Ostendorf, Benjamin N., et al.
Publicado: (2018)

Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes
por: Paracatu, Luana Chiquetto, et al.
Publicado: (2020)

Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
por: Schwind, Sebastian, et al.
Publicado: (2021)

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome
por: Tatetsu, Hiro, et al.
Publicado: (2023)

Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells
por: Menschikowski, Mario, et al.
Publicado: (2012)

Leukemic Stem Cell: A Mini-Review on Clinical Perspectives
por: Barreto, Igor Valentim, et al.
Publicado: (2022)

An EZH2‐dependent transcriptional complex promotes aberrant epithelial remodelling after injury
por: Le, Huy Q, et al.
Publicado: (2021)

Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes
por: Kataoka, Naoyuki, et al.
Publicado: (2021)

Myelodysplastic syndrome: validation of flow cytometry multilineage score system
por: de Araújo, Helena Varela, et al.
Publicado: (2020)

Chromosomal Aberrations Associated with Clonal Evolution and Leukemic Transformation in Fanconi Anemia: Clinical and Biological Implications
por: Meyer, Stefan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ojjsk0l085nob455905ptdq1as